BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 11982727)

  • 1. Management of refractory ascites and hepatorenal syndrome.
    Chutaputti A
    J Gastroenterol Hepatol; 2002 Apr; 17(4):456-61. PubMed ID: 11982727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascites and Hepatorenal Syndrome.
    Adebayo D; Neong SF; Wong F
    Clin Liver Dis; 2019 Nov; 23(4):659-682. PubMed ID: 31563217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome.
    Suzuki H; Stanley AJ
    QJM; 2001 Jun; 94(6):293-300. PubMed ID: 11391027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural history and management of hepatorenal disorders: from pre-ascites to hepatorenal syndrome.
    Blendis L; Wong F
    Clin Med (Lond); 2003; 3(2):154-9. PubMed ID: 12737373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of ascites and hepatorenal syndrome.
    Piano S; Tonon M; Angeli P
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in treatment of massive ascites and hepatorenal syndrome.
    Gerbes AL; Gulberg V
    World J Gastroenterol; 2006 Jan; 12(4):516-9. PubMed ID: 16489662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update.
    Rössle M; Gerbes AL
    Gut; 2010 Jul; 59(7):988-1000. PubMed ID: 20581246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome.
    Senzolo M; Cholongitas E; Tibballs J; Burroughs A; Patch D
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1143-50. PubMed ID: 17033432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatorenal syndrome: diagnosis, treatment and prevention].
    Egerod Israelsen M; Gluud LL; Bendtsen F; Møller S; Krag AA
    Ugeskr Laeger; 2013 May; 175(22):1562-6. PubMed ID: 23721840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatorenal syndrome and ascites--questions and answers.
    Bernardi M; Blendis L; Burroughs AK; Laffi G; Rodes J; Gentilini P
    Liver; 1999; 19(1 Suppl):15-74. PubMed ID: 10227000
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.
    Rössle M; Ochs A; Gülberg V; Siegerstetter V; Holl J; Deibert P; Olschewski M; Reiser M; Gerbes AL
    N Engl J Med; 2000 Jun; 342(23):1701-7. PubMed ID: 10841872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.
    European Association for the Study of the Liver
    J Hepatol; 2010 Sep; 53(3):397-417. PubMed ID: 20633946
    [No Abstract]   [Full Text] [Related]  

  • 16. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
    Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
    Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis.
    Bai M; Qi XS; Yang ZP; Yang M; Fan DM; Han GH
    World J Gastroenterol; 2014 Mar; 20(10):2704-14. PubMed ID: 24627607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatorenal syndrome.
    Biswas KD; Jain AK
    Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ascites].
    Maier KP
    Praxis (Bern 1994); 2008 Jul; 97(14):772-8. PubMed ID: 18717459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
    Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
    Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.